Role of hypoxia-inducible factor 1alpha in the integrity of articular cartilage in murine knee joints by unknown
Available online http://arthritis-research.com/content/10/5/R111Open AccessVol 10 No 5Research article
Role of hypoxia-inducible factor 1alpha in the integrity of articular 
cartilage in murine knee joints
Kolja Gelse1,2,3, David Pfander4, Simon Obier1, Karl X Knaup3, Michael Wiesener3, 
Friedrich F Hennig2 and Bernd Swoboda1
1Division of Orthopaedic Rheumatology, University of Erlangen-Nuremberg, Rathsberger Straße 57, Erlangen 91054, Germany
2Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Krankenhausstraße 12, Erlangen 91054, Germany
3Interdisciplinary Center for Clinical Research, University Hospital Erlangen, Glückstraße 6, Erlangen 91054, Germany
4Division of Orthopaedic Rheumatology, Hufeland-Clinic, Langensalzaer Landstraße 1, Muehlhausen 99974, Germany
Corresponding author: Kolja Gelse, kolja.gelse@web.de
Received: 28 May 2008 Revisions requested: 30 Jun 2008 Revisions received: 18 Aug 2008 Accepted: 12 Sep 2008 Published: 12 Sep 2008
Arthritis Research & Therapy 2008, 10:R111 (doi:10.1186/ar2508)
This article is online at: http://arthritis-research.com/content/10/5/R111
© 2008 Gelse et al.; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction Chondrocytes have to withstand considerable
hypoxic conditions within the avascular articular cartilage. The
present study investigated the effects of inhibiting or stabilizing
hypoxia-inducible factor (HIF)-1α by 2-methoxyestradiol or
dimethyloxaloylglycine on the progression of osteoarthritis in
murine knee joints.
Methods 2-Methoxyestradiol was injected six times over a
period of 2 weeks into the left knee joint of Balb/C mice. Joints
were assessed by histochemical and immunohistochemical
methods, 3 weeks and 12 weeks following the first injection.
Dimethyloxaloylglycine, an inhibitor of HIF-degrading prolyl-
hydroxylases, was injected into the left knee joints of STR/ORT
mice once a week over the entire period of 12 weeks. Right knee
joints that received a saline solution served as controls. In
addition, the effects of dimethyloxaloylglycine on HIF-1 target
gene expression and on collagen metabolism were analyzed in
vitro.
Results Injection of 2-methoxyestradiol led to osteoarthritic
changes in the treated knee joints of Balb/C mice. The first signs
of osteophyte formation were observed in the knee joints after 3
weeks, followed by progressive destruction of the articular
cartilage at 12 weeks that was not, however, accompanied by
inflammatory reactions. Injection of dimethyloxaloylglycine could
not prevent severe osteoarthritis that spontaneously developed
in the knee joints of STR/ORT mice. In chondrocyte cultures,
administration of dimethyloxaloylglycine resulted in an
upregulation of Sox9 expression. Such a stimulatory effect was
not observed, however, for the expression of type II collagen,
which might be the indirect consequence of intracellular
collagen retention observed by immunofluorescence or of
increased expression of IL-1β and IL-6.
Conclusions Induction of osteoarthritis by 2-methoxyestradiol
demonstrates the importance of HIF-1 in maintaining the
integrity of hypoxic articular cartilage. Stabilization of HIF-1 by
dimethyloxaloylglycine, however, was not of therapeutic value,
since this nonselective prolyl-hydroxylase inhibitor also
interferes with proper collagen metabolism and induces the
expression of catabolic cytokines
Introduction
Articular cartilage is a unique connective tissue that physiolog-
ically lacks blood vessels. This lack of vessels inevitably coin-
cides with a significantly reduced oxygen level within the
tissue, which requires well-adapted mechanisms to ensure
survival of the resident cells. The transcription factor hypoxia-
inducible factor (HIF)-1 represents one important element in
maintaining proper cellular functions under such hypoxic con-
ditions [1]. As for chondrocytes, HIF-1 is also of great impor-
tance by promoting the synthesis of relevant extracellularPage 1 of 12
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mediated by transactivation of Sox9, a key transcription factor
for many cartilage-specific genes involving metabolism and
chondrogenic differentiation [3,4].
The importance of HIF-1 for the formation and maintenance of
cartilage tissue has been demonstrated in conditional knock-
out mice in which deletion of its oxygen-sensitive subunit HIF-
1α severely interfered with proper skeletal development and
led to massive cell death within the center of the forming car-
tilaginous elements [1]. On the contrary, another study in mice
with conditional inactivation of the von Hippel–Lindau protein
demonstrated that the resulting stabilization of HIF-1α by
inhibiting its degradation increased the deposition of extracel-
lular cartilage matrix in the growth plate [5].
The regulation of HIF-1 activity is complex. Under normoxic
conditions, HIF-1α is degraded rapidly. In the presence of
molecular oxygen, two prolyl residues within the oxygen-
dependent degradation domain of the HIF-1α protein are
hydroxylated by HIF-specific oxygen-dependent prolyl-hydrox-
ylases [6]. This conversion allows capture by the von Hippel–
Lindau protein complex followed by ubiquitinylation and rapid
degradation by the proteasome [6,7]. The synthesis of HIF-1α
can be activated by a variety of factors, including reactive oxy-
gen species, glucose metabolites, and a number of growth
factors or cytokines involving the phosphatidylinositol 3-kinase
or extracellular signal-regulated kinase/mitogen-activated pro-
tein kinase pathway [8-10].
In osteoarthritic cartilage, the protein levels of HIF-1 are signif-
icantly increased and its activity correlates to the severity of
degenerative cartilage changes [9,11]. According to the bio-
logical functions of HIF-1, it may be assumed that HIF-1 exerts
a compensatory protective role in the disease process rather
than promoting the progression of the disease.
To further prove this hypothesis, we established two animal
models. The first model served to investigate whether inhibi-
tion of HIF by 2-methoxyestradiol (2ME2) promotes or initiates
osteoarthritis (OA) in the murine knee joint. In contrast to con-
ditional knockout mice, the chemical inhibition allows one to
investigate the effects in adult joints in an otherwise healthy
organism, and therefore seems better suited referring to stud-
ies on OA. Although the exact mechanism of HIF inhibition by
2ME2 has still to be defined, 2ME2 has been shown to reliably
decrease the levels of HIF-1α protein in chondrocytes and a
number of other cell types – and as a consequence also
decreases the expression of a number of HIF-1 target genes
including phosphoglycerate kinase 1 (PGK1), vascular
endothelial growth factor A, and glucose transporter type 1
[12-14].
The second animal model was used to investigate whether
stabilization of HIF-1α by dimethyloxaloylglycine (DMOG) pre-
vents or delays degenerative changes in STR/ORT mice.
DMOG is known to efficiently inhibit prolyl-hydroxylases that
mediate the oxygen-dependent degradation of HIF [15]. STR/
ORT mice served as an OA model since this strain spontane-
ously develops degenerative changes in the knee joints [16-
19].
Materials and methods
Cell isolation and culture
Primary human chondrocytes were isolated from knee carti-
lage of six patients undergoing total knee replacement for OA
as described previously [12]. All of the samples were obtained
after the patients gave their informed consent. Our institutional
ethics committee approved the study protocol.
To minimize the effect of chondrocyte dedifferentiation, only
first-passage chondrocytes were used in the present study.
After digestion, cells were plated at a cell density of 100,000
cells/cm2 in 24-well plates for RNA isolation or in Flexi-Perm
culture chambers (Greiner Bio-One, Solingen, Germany) for
immunohistochemistry.
First, the cells were cultured under normoxic conditions (21%
oxygen) for 3 days in DMEM containing 10% FCS, 2 mM
glutamine and 50 U/ml streptomycin/penicillin at 37°C. For
gene expression analyses, confluent cells were subsequently
treated with different concentrations of DMOG ranging from
0.1 to 1 mM or with 2ME2 in concentrations of 100 or 200
μM, and were cultured either under normoxic (21% oxygen) or
hypoxic conditions (1% oxygen) for 24 hours before harvest-
ing. Since 2ME2 is dissolved in dimethyl sulfoxide (DMSO), a
portion of the cells was exposed to 1% DMSO alone, which
served as an additional control. For hypoxic conditions, the
chondrocytes were kept in a sealed incubator (Binder GmbH,
Tuttlingen, Germany), and flushed with gas mixture containing
1% oxygen, 5% carbon dioxide and balanced with 94% N2 in
a humidified atmosphere. For immunohistochemistry, the cells
were treated with 1 mM DMOG and were cultured under nor-
moxic conditions for 5 days.
Animal experiments
The present study investigated the effect of 2ME2 on female
Balb/C mice (Charles River, Sulzfeld, Germany) and the effect
of DMOG on female STR/ORT mice (Harlan Winkelmann,
Borchen, Germany). The animals were fed a standard labora-
tory diet ad libitum and were allowed to move freely in their
cages at any time. For all procedures, the mice were anesthe-
tized by inhalation with 1.5 l/min isofluran (Baxter, Untersch-
leißheim, Germany) and 1.5 l/min oxygen.
In 14-week-old Balb/C-mice (n = 32), 2ME2 (20 μl) at con-
centrations of 10 μM (group 1, n = 16) or 100 μM (group 2, n
= 16) was carefully injected with a 27G needle into the knee
joints through the patella tendon into the intercondylar notch
region to avoid contact with the articular surface. The treat-Page 2 of 12
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during the course of the first 2 weeks of the experiment. The
animals received no further treatment for the remaining 1 week
or 10 weeks, respectively. A control solution (20 μl) was
injected into the right knee joints of all Balb/C mice at the
same time. Since 2ME2 was dissolved in a 1% DMSO saline
solution, the control solution (0.9% NaCl) was also supple-
mented with 1% DMSO. Preliminary experiments in vitro
excluded any toxic effects of 1% DMSO. The mice were killed
either after 3 weeks (n = 8 per group) or 12 weeks (n = 8 per
group) by cervical dislocation.
In 8-week-old STR/ORT mice (n = 8), 20 μl of a 1 mM DMOG
solution were injected into the left knee joints once per week
throughout the whole period of 12 weeks. DMOG was dis-
solved in 0.9% NaCl. As a control, 20 μl saline solution was
injected into the right knee joints at the same time. The STR/
ORT mice were sacrificed after 12 weeks.
All knee joints were fixed in 4% paraformaldehyde for 12 hours
and were decalcified in 0.5 M ethylenediamine tetraacetic
acid/2% paraformaldehyde for 2 weeks. After standard
processing, the samples were embedded in paraffin. Serial
frontal 5 μm sections of the knee joints were cut and further
processed for histological and immunohistological analysis.
All procedures on the animals were approved by the appropri-
ate institutional Review board.
Histological assessment
After deparaffinization, serial sections were stained with tolui-
dine blue or with H&E for further histological investigation.
Sections from treated joints and control joints were compared
by scoring systems investigating the articular cartilage layer,
osteophyte formation and synovial tissue.
The articular cartilage layer was evaluated referring to a
mouse-specific scoring system described by Walton [16]
(grade 0 = normal; grade 1 = superficial fibrillation, alterations
in proteoglycan staining; grade 2 = deeper fissures, beginning
loss of cartilage tissue; grade 3 = substantial loss of uncalci-
fied cartilage tissue, fissures extending to the subchondral
bone; grade 4 = complete loss of cartilage tissue, exposure of
bone).
Staging of osteophyte formation was analyzed according to a
previously described system [20] (grade 0 = normal; grade 1
= fibrous outgrowths; grade 2 = fibrocartilaginous tissue;
grade 3 = mature cartilage tissue; grade 4 = cellular hypertro-
phy, bone core).
The evaluation of the synovial layer refers to the additive score
by Krenn and colleagues [21], including thickening of the syn-
ovial cell lining (grade 0 = single cell layer; grade 1 = two to
three cell layers; grade 2 = four to five cell layers; grade 3 =
more than five cell layers), synovial inflammation (grade 0 = no
inflammation; grade 1 = single lymphocytes; grade 2 = lym-
phocytic aggregations; grade 3 = formation of lymph follicles)
and the cell density of the synovial stroma (grade 0 = normal
cell density; grade 1 = slightly increased cellular density;
grade 2 = increased cellular density, 3 = high cellular density,
presence of multinuclear giant cells).
The sections were analyzed blind, by three independent
experts.
Detection of cellular hypoxia
Pimonidazole hydrochloride 60 mg/kg (Hydroxyprobe™-1 Plus
Kit; Chemicon, Temecula, CA, USA) was injected intraperito-
neally in Balb/C mice (n = 6). The animals were sacrificed after
24 hours. The knee joints and other organs were fixed in 4%
paraformaldehyde for 12 hours and were processed as
described above. Representative sections were immunos-
tained using a FITC-conjugated monoclonal antibody (Hydrox-
yprobe™-1 Mab1; Chemicon). Immunostaining was performed
according to the manufacturer's recommendations. Antibody
binding was detected by a peroxidase-labeled secondary anti-
body against FITC and was visualized by diaminobenzidine tet-
rahydrochloride (Chemicon, Temecula, CA, USA). All sections
were counterstained with hematoxylin.
Immunohistochemistry
For detection of type II collagen, sections were pretreated with
0.2% hyaluronidase (Roche, Mannheim, Germany) in PBS (pH
5.0) for 60 minutes, and subsequently treated with pronase (2
mg/ml in PBS, pH 7.3; Sigma-Aldrich, Munich, Germany) for
60 minutes at 37°C. No enzymatic pretreatment of the sec-
tions was required for detection of CD45. Nonspecific anti-
body binding was blocked with 5% BSA in PBS.
For signal amplification and visualization of HIF-1α, an amplifi-
cation system (CSA kit; Dako, Hamburg, Germany) was used
according to the manufacturer's instructions. Antigen retrieval
was performed for 6 minutes in preheated Dako target retrieval
solution, using a pressure cooker.
The slides were incubated overnight at 4°C with polyclonal
rabbit antibodies against HIF-1α (Cayman Chemical, Ann
Arbor, MI, USA) in a 1:10,000 dilution, with monoclonal mouse
anti-human type II collagen antibodies (MP Biomedicals, Irvine,
CA, USA) in a 1:500 dilution or with monoclonal rat anti-
mouse CD45 antibodies (BD Pharmingen, Heidelberg, Ger-
many) in a 1:200 dilution, followed by washing with Tris-buff-
ered saline. For detection of type II collagen or CD45, the
sections were subsequently incubated with a biotinylated don-
key anti-mouse secondary antibody (Dianova, Hamburg, Ger-
many) or a biotinylated rabbit anti-rat secondary antibody
(Vector Laboratories, Burlingame, CA, USA), followed by
treatment with a complex of streptavidin and biotinylated alka-Page 3 of 12
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and were counterstained with hematoxylin.
For visualization of HIF-1α, a catalyzed signal amplification kit
(Dako) based on a streptavidin–biotin–peroxidase reaction
was used. 3,3'-Diaminobenzidine served as the chromogen for
the peroxidase reaction.
Immunofluorescence
After fixation of the cultured cells with 70% ethanol, the slides
were blocked with 5% BSA and were incubated with mono-
clonal mouse anti-human type II collagen antibodies (MP Bio-
medicals) in a 1:500 dilution for 50 minutes at 37°C. After
washing with PBS, the cells were incubated with a Cy3-con-
jugated anti-mouse antibody (Dianova) diluted at a ratio of
1:100 for 45 minutes. After washing with Tris-buffered saline,
the slides were covered with a mounting medium containing
4',6'-diamidino-2-phenylindole (Vector, Peterborough, UK)
and were analyzed by fluorescence microscopy. Control slides
were incubated with equivalent concentrations of mouse IgG.
TUNEL staining
For the detection of in situ DNA breaks, the TUNEL reaction
was applied using the In Situ Cell Death Detection Kit, AP
(Roche, Mannheim, Germany). The proteinase K pretreatment
as well as the terminal deoxynucleotidyl transferase concentra-
tions were carefully titrated to allow sensitive and specific
detection of apoptotic cell nuclei. After deparaffinization, the
sections were washed in PBS and digested with proteinase K
(20 μg/ml; Boehringer, Ingelheim, Germany) for 15 minutes at
37°C. After washing with PBS, sections were incubated with
terminal deoxynucleotidyl transferase solution in reaction
buffer at a volume ratio of 9:1 at 37°C for 1 hour followed by
extensive washing. The converter AP antibody was added for
30 minutes at 37°C. After washing, detection was performed
by fast red staining and counterstaining with hematoxylin.
RNA isolation and real-time RT-PCR
The expression levels of Sox9, type II collagen α1-chain
(Col2A1), type I collagen α2-chain (Col1A2), PGK1, IL-1β, IL-
6 and TNFα under the influence of different concentrations of
DMOG or 2ME2 were compared for normoxic or hypoxic con-
ditions by real-time RT-PCR using RNA preparations from cul-
tured primary human chondrocytes of three different donors.
Total RNA was isolated from the cells by the Nucleo-Spin-
RNA-II-Kit (Clontech Laboratories, Mountain View, CA, USA).
Quantitative real-time RT-PCR was performed with an ABI
Prism 7900 sequence detection system (Applied Biosystems,
Foster City, CA, USA) and a QuantiTect Probe RT-PCR Kit
(Qiagen, Chatsworth, CA, USA) for one-step RT-PCR.
The relative quantification of gene expression was performed
using the standard curve method. For each sample, the relative
amount of the target mRNA was determined and normalized to
β2-microglobulin mRNA.
The primer and probe sets for Sox9, Col1A2, Col2A1, IL-1β,
IL-6 and TNFα were purchased from Applied Biosystems and
from Celera Genomics (Rockville, MD, USA). The primer and
probe sets for β2-microglobulin and PGK1 were designed by
the primer express software (PerkinElmer, Emeryville, CA,
USA) as described previously [13].
Statistical analysis
All data are presented as the mean ± standard deviation. The
analysis of the morphological scores was performed using the
Mann–Whitney test. The results of quantitative gene expres-
sion were analyzed using a two-sided Student's t test. P <0.05
was considered significant.
Results
Tissue hypoxia in articular cartilage and meniscal tissue
The intraperitoneal injection of pimonidazole hydrochloride in
Balb/C mice allowed investigation of intracellular hypoxia.
Pimonidazole is a 2-nitroimidazole that is reductively activated
and becomes covalently bound to thiol-containing proteins
only in hypoxic cells [22]. Immunohistochemical detection of
pimonidazole–protein adducts revealed strong staining in
articular chondrocytes and meniscal cells even in superficial
layers (Figure 1a,b). Osteocytes, synoviocytes, muscle cells
and cells of other tissues and organs were negative for this
hypoxia marker.
Repeated intraarticular injection of 2-methoxyestradiol 
induces osteoarthritic changes in Balb/C mice
Two different concentrations of 2ME2 (group 1, 10 μM; group
2, 100 μM) were injected six times into the left knee joints over
the period of the first 2 weeks. Contralateral right knee joints
received a control solution. Coronar section of the patellofem-
Figure 1
Detection of tissue hypoxia. Pimonidazole hydrochloride (Hydroxy-
probe™-1 solution; Chemicon) was injected intraperitoneally in Balb/C 
mice and detected in hypoxic cells immunohistochemically after 24 
hours. Most (a), (b) articular chondrocytes and (a) meniscal cells 
stained positive for this hypoxic marker, whereas osteocytes and other 
mesenchymal cells were negative. F, femoral condyle; M, meniscus; T, 
tibial plateau. Bars = 100 μm.Page 4 of 12
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assessed for degenerative changes of the articular cartilage,
for osteophyte formation and for synovitis. In the control joints,
the administration of the control solution (1% DMSO in 0.9%
NaCl) did not induce degenerative changes of the articular
cartilage or relevant osteophyte formation within the observa-
tion period of 12 weeks (Figures 2a,c,e and 3a,b).
The joints treated with 2ME2 were characterized at 3 weeks
by beginning osteophyte formation and the first signs of
degenerative changes of the articular cartilage layer. Osteo-
phytes were still premature and were characterized by fibrous
and fibrocartilaginous tissue lacking a vascularized bone core
(data not shown). After 12 weeks, 2ME2-treated joints differed
significantly from control joints with respect to degeneration of
the articular cartilage and osteophyte formation (Figures 2b,d,f
and 3a,b). The formation of osteophytes was present at the
margins of the articular surface in all joint compartments. The
articular cartilage showed signs of degeneration, with fissuring
and loss of superficial layers of the matrix (Figure 2b,d,f). The
menisci also revealed signs of degenerative changes with fray-
Figure 2
Histomorphology of treated knee joints of Balb/C micej i  f l /  i . The joints were 
analyzed 12 weeks after the first intra-articular injection of (a), (c), (e) 
the control solution or (b), (d), (f) 100 μM 2-methoxyestradiol (2ME2). 
In the control joints, representative coronar sections of (a) the patel-
lofemoral joint, as well as (c) the medial knee compartment and (e) the 
lateral knee compartment, did not show relevant signs of cartilage 
degeneration or osteophyte formation. (c) The menisci remained intact. 
2ME2-treated joints were characterized by significant osteophyte for-
mation (asterisks) and degeneration of the articular cartilage in (b) the 
patellofemoral joint, as well as in the (f) lateral and (d) medial knee com-
partments. Toluidine blue staining. Bar = 1 mm. P, patella; F, femur; T, 
tibia.
Figure 3
Osteophyte formation, destruction of the articular surface and synovial tissue analysis
tissue analysis. Analysis of (a) osteophyte formation, (b) destruction of 
the articular surface and (c) analysis of synovial tissue. The knee joints 
were treated by administration of 2-methoxyestradiol (2ME2) in Balb/C 
mice or of dimethyloxaloylglycine (DMOG) in STR/ORT mice. Bars 
show the mean ± standard deviation. *P <0.05, **P <0.01 versus 
untreated control joint.Page 5 of 12
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Figure 4
Effects of 2-methoxyestradiol and dimethyloxaloylglycine. Effects on synovial tissue, levels of hypoxia-inducible factor (HIF) 1α and viability of 
chondrocytes, and the effect of 2-methoxyestradiol (2ME2) on the expression of inflammatory cytokines. (a) to (d) Administration of 2ME2 (10 μM) 
or of dimethyloxaloylglycine (DMOG) (1 mM) did not induce inflammation or fibrosis of synovial tissue. A slight thickening of the synovial cell lining 
could be observed (b) 1 week following the repeated 2ME2 injections and (d) in osteoarthritic joints of STR/ORT mice. Immunostaining for CD45 
revealed no relevant invasion of leukocytes into synovial tissue in (e) control joints, (f), (g) 2ME2-treated joints or (h) DMOG-treated joints. Large 
amounts of CD45-positive cells could be detected within bone marrow spaces. (i) Immunohistochemical detection of HIF-1α revealed strong stain-
ing in most articular chondrocytes of control joints of Balb/C mice. (j) 2ME2-treated joints showed a distinct reduction of HIF-1α-positive cells with 
less intense staining at 3 weeks. (k) Number of positive cells recovered in joints analyzed at 12 weeks. (l) DMOG treatment did not relevantly influ-
ence the number of positive cells. (m) Apoptosis in articular cartilage, visualized by the TUNEL method, was virtually absent in the control joints. (n) 
Treatment with 2ME2 resulted in a considerable number of TUNEL-positive cells, particularly in superficial layers at 3 weeks. (o) After 12 weeks, the 
number of positive cells declined but was still elevated compared with controls. (p) Only few cells were TUNEL-positive in the articular cartilage of 
DMOG-treated STR/ORT mice. Expression of (q) IL-1β and (r) IL-6 in cultured articular chondrocytes determined by quantitative RT-PCR under 
21% or 1% oxygen and treatment with or without 2ME2. Treatment with the solvent dimethyl sulfoxide alone served as an additional control. Expres-
sion levels are shown as the mean ± standard deviation. *P <0.05. Bars = 100 μm.
Available online http://arthritis-research.com/content/10/5/R111ing and loss of tissue (Figure 2d). Luxation of the patella or
other defective positions of joint structures was not observed.
The analysis of the synovial membrane revealed slight thicken-
ing of the synovial lining up to three or four cell layers in both
treated joints and control joints at 3 weeks (Figure 4b). After
12 weeks, however, this tendency declined and the synovial
membrane was again lined with a single cell layer in most
cases (Figure 4a,c). Signs of inflammation, increased cell den-
sity within the synovial stroma or fibrosis of the joint capsule
could not be observed in any animal during the whole obser-
vation period (Figure 4a,b,c,e,f,g). The additive synovial score
values of 2ME2-treated joints or control joints did not reach
the level of low-grade synovitis (additive score value 1 to 3)
(Figure 3c).
Dimethyloxaloylglycine does not prevent the induction 
of osteoarthritis in STR/ORT mice
To investigate the hypothesis that therapeutic stabilization of
HIF-1α in articular chondrocytes would prevent the progres-
sion of osteoarthritis in STR/ORT mice, we injected DMOG
into the left knee joints once a week during the entire period of
12 weeks. Right knee joints received a 0.9% NaCl control
solution at the same time. The joints were analyzed 12 weeks
following the first injection.
Twelve weeks after the first injection, the control joints of these
20-week-old mice showed distinct degenerative changes – as
described before for this and related mouse strains
[16,17,19]. The most prominent degenerative changes were
observed in the medial compartment, with massive loss of the
cartilage substance and meniscal tissue to the point of com-
plete loss of cartilage tissue with exposure of the subchondral
bone (Figure 5a,c,e).
The intraarticular administration of DMOG did not prevent
such degenerative changes. We could not determine any sig-
nificant positive or negative effect of DMOG with respect to
degenerative changes of the articular cartilage (Figures 3a,b
and 5b,d,f). Comparable with the control joints, the medial
knee compartment showed massive degenerative changes
culminating in a complete loss of articular cartilage tissue and
degeneration of the menisci. The cartilage of the lateral com-
partment and the patellofemoral joint was affected with fibrilla-
tion and fissuring. There were also no significant differences
between DMOG-treated joints and control joints with respect
to the formation of osteophytes. Osteophytes were present in
most cases at the margins of the joint surface of all compart-
ments (Figure 5b,d,f). Luxation of the patella was not
observed.
The analysis of the synovial membrane using the scoring sys-
tem of Krenn and colleagues [21] did not reveal any significant
differences between joints that received DMOG (0.87 ± 0.64)
or the control solution (1.0 ± 0.54) (Figure 3c). The slightly
elevated values could be ascribed to a moderate thickening of
the synovial cell lining, which was not, however, invaded by
lymphocytes or myeloid cells. An increased cellular density of
the stroma was not observed (Figure 4d,h). The additive score
values approximate the lower limit of low-grade synovitis (addi-
tive score value of 1 to 3), which is an often-observed phenom-
enon in advanced joint degeneration.
Detection of HIF-1α levels and cellular apoptosis in 
articular cartilage
Preceding in vitro studies of our group have recently demon-
strated the effect of 2ME2 on decreasing the protein level and
functional activity of HIF-1α as well as the HIF-stabilizing
effects of DMOG [12,13]. To prove the validity of the
described effects in vivo, we investigated staining for HIF-1α
immunohistochemically in treated joints and control joints. In
control joints of both mouse strains, HIF-1α could clearly be
detected in most articular chondrocytes throughout all layers
(Balb/C, Figure 4i; STR/ORT, data not shown). The distribu-
tion pattern of HIF-1α-staining correlated with the staining for
hypoxic cells with the Hydroxyprobe™ method (Chemicon).
Figure 5
Histomorphology of treated knee joints of STR/ORT mice. The joints 
were analyzed 12 weeks after the first intra-articular injection of (a), (c), 
(e) the control solution or (b), (d), (f) 1 mM dimethyloxaloylglycine 
(DMOG). In both control joints and treated joints, representative coro-
nar sections of the (a), (b) patellofemoral joint, (c), (d) the medial knee 
compartment and (e), (f) the lateral knee compartment showed distinct 
signs of cartilage degeneration. There were no significant differences 
between both groups. (c), (d) Particularly, the medial femoral condyle 
and medial tibial plateau were affected with complete loss of the articu-
lar cartilage (asterisks) and degeneration of the meniscus (arrowheads) 
in both groups. P, patella; F, femur; T, tibia. Toluidine blue staining. Bar 
= 1 mm.Page 7 of 12
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weeks in joints that received 2ME2 (Figure 4j). At 12 weeks,
the number of HIF-positive cells recovered and was compara-
ble with control joints (Figure 4k). Following DMOG treatment,
HIF-1α could strongly be detected in a high percentage of
articular chondrocytes (Figure 4l). HIF-1α could also be
detected in meniscal cells, but not in osteocytes, muscle cells,
synoviocytes or fibroblasts of ligaments (data not shown).
To investigate whether the inhibition of HIF-1α in hypoxic cells
induces apoptosis, we visualized in situ DNA breaks by the
TUNEL method. Apoptosis was virtually absent in the control
joints (Figure 4m). Following treatment with 2ME2, a consider-
able number of TUNEL-positive cells could be observed par-
ticularly in the superficial half of the articular cartilage layer at
3 weeks (Figure 4n), but not in other tissues such as bone,
synovial membrane or muscles. After 12 weeks, the percent-
age of TUNEL-positive cells in the cartilage declined but was
still elevated compared with control joints (Figure 4o). In STR/
ORT mice, we could not detect any significant amounts of
TUNEL-positive cells independent of the treatment with
DMOG (Figure 4p) or with control solution (data not shown).
2-Methoxyestradiol does not induce the expression of 
inflammatory cytokines in articular chondrocytes
The effect of 2ME2 on the expression of IL-1β, IL-6 and TNFα
in human articular chondrocytes was measured by quantitative
RT-PCR. Cultivation under hypoxia (1% oxygen) significantly
induced the expression of IL-1β compared with cultivation
under normoxic conditions. Under hypoxic conditions, the inhi-
bition of HIF-1α by administration of 100 μM 2ME2 did not
alter IL-1β expression compared with hypoxic controls. The
highest dose of 2ME2 (200 μM) led to a measurable, although
not significant, decrease in IL-1β expression. As a control, the
application of the solvent (1% DMSO) alone had no influence
on the expression (Figure 4q).
The expression of IL-6 was not influenced by the administra-
tion of 2ME2 or DMSO irrespective of the oxygen status (Fig-
ure 4r). We could not detect any relevant expression of TNFα
in the articular chondrocytes cultivated under normoxia or
hypoxia. TNFα could not be induced by 2ME2 or DMSO either
(data not shown).
Dimethyloxaloylglycine induces HIF-1-dependent genes 
but interferes with collagen synthesis
Since DMOG had no visible positive effect on the progression
of OA, further studies explored its biological effects – particu-
larly its influence on the synthesis of type II collagen and the
expression of cartilage-specific genes. Immunohistochemical
staining for type II collagen differed from DMOG-treated joints
to control joints. In the latter, type II collagen was distributed
homogeneously throughout the extracellular matrix apart from
some irregularities due to degenerative changes (Figure 6a).
DMOG-treated joints, however, were characterized by an
intracellularly and pericellularly pronounced staining pattern
for type II collagen, particularly in the superficial half of the
articular cartilage layer (Figure 6b). Similar observations were
made in primary chondrocyte monolayer cultures employing
immunofluorescence staining for type II collagen. As expected,
nontreated chondrocytes typically secreted type II collagen to
form an extracellular network (Figure 6c). On the contrary,
addition of DMOG to the cultures leads to strong intracellular
signals in the form of vesicle-like structures with virtually no or
drastically reduced deposition of type II collagen in the extra-
cellular space (Figure 6d).
We further investigated the effect of DMOG on the expression
of two HIF-regulated genes, PGK1 and SOX9, using quantita-
tive RT-PCR. Furthermore, the influences on the expression of
Col1A2 and Col2A1 genes, which encode the structural ele-
ments for type I and type II collagen fibrils, were determined.
DMOG significantly increased the expression of PGK1 in a
dose-dependent manner (Figure 6e). This effect was more
pronounced under normoxic conditions that are characterized
by a physiologically lower activity of HIF-1. This supports the
fact that the stabilization of HIF-1α by DMOG also increases
its transactivating activity and thus secondarily increases the
expression of HIF target genes. The expression of Sox9, a
recently identified HIF target gene, was also stimulated in a
dose-dependent manner by DMOG, both under normoxic and
hypoxic culture conditions (Figure 6f).
Different results were observed, however, for the expression of
Col1A2 and Col2A1. The transcription of Col2A1, which is a
target of the transcription factor SOX9 and which encodes for
cartilage-specific collagen fibers, was significantly increased
under hypoxia but was not stimulated by DMOG. The highest
concentration of DMOG (1 mM) even led to a measurable,
although not significant, decrease in Col2A1 expression, both
under normoxia and hypoxia (Figure 6g). Even more impres-
sively, DMOG inhibited the expression of Col1A2 in a highly
significant and dose-dependent manner irrespective of the
oxygen status (Figure 6h).
DMOG induced the expression of the inflammatory cytokines
IL-1β (Figure 6i) and IL-6 (Figure 6j) in a dose-dependent man-
ner. DMOG did not, however, lead to a measurable enhanced
expression of TNFα in articular chondrocytes (data not
shown).
Discussion
The present work documents the importance of the transcrip-
tion factor HIF-1 for maintaining the integrity of hypoxic articu-
lar cartilage. The functional inhibition of HIF-1 coincided with
increased apoptosis of articular chondrocytes and led to
degenerative changes in murine knee joints. The study there-
fore supports the results of Schipani and colleagues obtained
from conditional HIF-knockout mice in which cell death in the
center of cartilaginous elements of the developing skeletonPage 8 of 12
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Figure 6
Biological effects of dimethyloxaloylglycine. In control joints of STR/ORT mice, (a) immunohistochemical detection of type II collagen reveals homo-
geneous staining within the extracellular matrix apart from some irregularities due to degenerative changes in the superficial layers. (b) In contrast, 
administration of dimethyloxaloylglycine (DMOG) results in accumulation of type II collagen located intracellularly/pericellularly in the superficial layer. 
(c) Type II collagen-immunofluorescence of cultured nontreated primary chondrocytes typically displays a pericellular network of type II collagen fib-
ers. (d) DMOG treatment of primary chondrocytes in monolayer culture leads to an intracellular retention of vesicle-like structures that stain positive 
for type II collagen. Expression of (e) phosphoglycerate kinase 1 (PGK1), (f) Sox9, (g) type II collagen α1-chain (Col2A1), (h) type I collagen α2-
chain (Col1A2), (i) IL-1β and (j) IL-6 in cultured articular chondrocytes determined by real-time RT-PCR dependent on treatment with or without 
DMOG under 21% or 1% oxygen. Expression levels are shown as the mean ± standard deviation. *P <0.05, **P <0.01. Bar = 100 μm.
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HIF-1α, plays an important role in chondrogenesis and joint
formation – and HIF-1α was recently shown to activate the
promotor of SOX9, which is a key regulator of chondrocyte dif-
ferentiation [3,4,23,24].
The naturally occurring derivate of estradiol, 2ME2, is consid-
ered a substance with anti-tumorigenic properties and is also
accepted as a HIF inhibitor. Although its exact mechanism of
action is not yet known, the HIF-1-inhibiting properties of
2ME2 have been suggested to be linked to a microtubule
depolymerizing effect [14,25,26]. 2ME2 is a substance cur-
rently investigated in clinical trials for the treatment of tumors,
and its systemic application was shown to be well tolerated
with no relevant negative side effects in oxygenated organs
[27]. In vitro studies also confirm that 2ME2 in moderate con-
centrations has no direct toxic effects on slow-dividing nontu-
mor cells but does lead to a reliable inhibition of HIF-1 [12,13].
The present study has shown for the first time that repeated
intraarticular administration of 2ME2 decreased the number
and the intensity of HIF-1α-positive cells. The relevance of tis-
sue hypoxia even in thin murine articular cartilage was demon-
strated by the Hydroxyprobe™ (Chemicon) method, which
detected hypoxic cells in deep and superficial layers of avas-
cular cartilage and mensical tissue. This observation indicates
the relevance of the transcription factor HIF-1 even in relatively
thin murine articular cartilage. One can therefore conclude that
2ME2-exposed cells were no longer able to adapt to a hypoxic
environment, resulting in impaired cell functions and cell death
– which is presumably the primary pathomechanism for the
degeneration of the cartilage tissue in this model. Of course,
one has to consider that the molecular mechanism of cartilage
degeneration induced by 2ME2 differs to some extent from the
pathogenesis of primary OA, in which apoptotic cell death is
supposed to play an inferior role [28]. Nevertheless, the mor-
phological changes strikingly resembled those of osteoar-
thritic lesions. The lack of synovial inflammation and the absent
induction of inflammatory cytokines suggest that cartilage
destruction by 2ME2 does not depend on inflammatory reac-
tions, but rather on an impact on the chondrocyte function
itself.
The second objective of the present work was to investigate
whether stabilization of HIF-1 could prevent the initiation or
progression of murine OA in STR/ORT mice, which belong to
a family of mouse strains that develop spontaneously degener-
ative changes [16,17,19]. In preceding in vitro experiments,
DMOG was shown to effectively stabilize HIF-1 by inhibiting
its degradation [12,15].
Despite the stimulatory effects on SOX9 expression in vitro,
the repeated intra-articular injection of DMOG did not prevent
the progression of OA in the knee joints of STR/ORT mice.
Neither osteophyte formation nor the score for destruction of
the articular cartilage differed between DMOG-treated joints
and control joints. Degeneration of the articular cartilage and
osteophyte formation were present in all knee compartments.
Consistent with previous reports, cartilage degeneration was
most prominent in the medial compartment. This phenomenon
might be a consequence of mechanical overloading due to the
varus deformity of the hind limbs [17,19].
The following three reasons may account for the failure of
DMOG to have a beneficial effect. Firstly, endogenous HIF-1
levels may be sufficient in articular chondrocytes, and were
even shown to be elevated in OA cartilage [9,11,29]. The data
of the present study show that articular chondrocytes strictly
depend on sufficient HIF-1 activity to ensure their cellular sur-
vival within the hypoxic matrix. Other studies on other cell
types, however, describe a contradictory role of HIF-1α in
modulating cell viability and apoptosis, which may depend on
multitude factors including the cell type or the physico-chemi-
cal environment [30-32]. The physiological function of HIF-1α
may therefore depend on a well-balanced activity, and surplus
levels may not necessarily have further protective effects on
the cells or even induce proapoptotic or other detrimental
events that could not be detected by the TUNEL method used
in the present study.
Secondly, DMOG represents rather a nonselective inhibitor of
prolyl-hydroxylases. To our knowledge, agents that selectively
inhibit the HIF-degrading prolyl-hydroxylase have not so far
been established. DMOG not only inhibits the HIF prolyl-
hydroxylase, but also interferes with collagen prolyl-hydroxy-
lases [33]. The latter are involved in post-transcriptional
processing of collagen fibers and formation of the triple heli-
ces. The hydroxylation of proline residues is essential for the
formation of intramolecular hydrogen bonds and contributes to
the stability of the triple-helical conformation [34]. The intrac-
ellular accumulation of type II collagen observed by immuno-
histochemistry and immunofluorescence can therefore be
ascribed to impaired collagen processing, which is known to
interfere with proper secretion of fibrillar collagens [35]. As a
consequence, retention and accumulation of collagen mole-
cules may act via a negative feedback loop on their gene
expression. Downregulation of the collagen gene expression
was more prominent for Col1A2 than for Col2A1. Two mech-
anisms may counteract specifically the expression of Col2A1.
The described putative suppressive effect by intracellular col-
lagen retention may at least partly be neutralized by a stimula-
tory effect via increased SOX9 expression, which is known to
function as an enhancer for Col2A1 [36].
Thirdly, HIF-1α not only mediates prochondrogenic effects (for
example, by enhanced SOX9 expression), but is also involved
in catabolic events. HIF-1α was recently shown to be essential
for myeloid cell-mediated inflammation [37]. Elevation of HIF-
1α levels by DMOG increased the expression of the catabolic
cytokines IL-1β and IL-6. IL-1β has recently been shown to bePage 10 of 12
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HIF-1-binding sites resulting in an enhanced expression under
hypoxia [38]. Although moderate doses of IL-1β also support
anabolic effects on cartilage metabolism to some degree
[39,40], it is well proven that this cytokine generally mediates
catabolic events by canonical pathways and, therefore, may
also account for the negative effect on collagen expression in
the present study.
Conclusion
The data from the present work underline the requirement of
adequate levels of HIF-1 for the viability of chondrocytes and
for the maintenance of the integrity of hypoxic articular carti-
lage. One has to consider, however, that surplus levels of HIF-
1α may also exert catabolic effects – for example, by inducing
the cytokines IL-1β and IL-6. HIF-1α may thus exert a paradox-
ical role in cartilage. On the one hand, HIF-1α ensures energy
supply and survival of chondrocytes exposed to a hypoxic envi-
ronment. Furthermore, HIF-1α stimulates the expression of a
number of cartilage-specific genes. On the other hand, HIF-1α
also promotes catabolic pathways and may also trigger proa-
poptotic events. In view of the data of the present study and
the data from the literature, HIF-1α may be considered an
important element in balancing anabolism and catabolism as
well as cellular protection and cell death in cartilage and many
other tissues. In this context, the question still remains open if
elevated HIF-1α levels in OA exert a compensatory protective
role or trigger the disease process.
In view of the detrimental side effect of DMOG on collagen
metabolism due to its lack of specificity, one cannot currently
rule out that more specific agents might nevertheless have
beneficial effects. The future development of strictly selective
inhibitors of HIF-degrading prolyl-hydroxylases therefore
seems worthwhile, since stabilization of HIF may be of poten-
tial therapeutic value at least for cartilage repair approaches by
supporting chondrogenic differentiation (for example, via stim-
ulating expression of SOX9).
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